TY - JOUR
T1 - Hybrid strategy in neonates with ductal-dependent systemic circulation and multiple risk factors
AU - the Children's National Hospital Hybrid Working Group
AU - Ceneri, Nicolle M.
AU - Desai, Manan H.
AU - Tongut, Aybala
AU - Ozturk, Mahmut
AU - Ramakrishnan, Karthik
AU - Staffa, Steven J.
AU - Zurakowski, David
AU - Donofrio, Mary T.
AU - Downing, Tacy
AU - d'Udekem, Yves
AU - Jonas, Richard A.
AU - Yerebakan, Can
AU - Clauss, Sarah
AU - Kalinger, Kathleen
AU - Kanter, Joshua
AU - Munoz, Ricardo
AU - Peer, Syed M.
AU - Sinha, Pranava
AU - Wernovsky, Gil
N1 - Publisher Copyright:
© 2022 The American Association for Thoracic Surgery
PY - 2022/11
Y1 - 2022/11
N2 - Objective: The study objective was to analyze outcomes of the hybrid strategy for ductal-dependent systemic circulation consisting of bilateral pulmonary artery banding with or without ductal stenting followed by delayed Norwood-type palliation or comprehensive stage II operation in high-risk neonates. Methods: A retrospective analysis was performed between December 2017 and March 2021. Thirty high-risk neonates underwent palliation with bilateral pulmonary artery banding: 11 with prostaglandin therapy and 19 with ductal stenting. Median (range) age and body weight of patients at hybrid stage I were 3 days (0-43) and 2.9 kg (1.1-4.2), respectively. Operative and interstage mortality, morbidity, and reintervention rates were assessed. Results: Overall survival was 70% (21/30) at a median follow-up time of 9 months (range, 0-37) from hybrid stage I. Operative survival for hybrid stage I was 90% (27/30), of which 2 patients received palliative care, and there was 1 interstage death (4%, 1/27). After hybrid stage I, 37% of patients had a reintervention, and 3% (n = 1) used extracorporeal membrane oxygenation before the next stage of repair. Five patients are awaiting second-stage operation, and 9 patients are awaiting Fontan completion. Conclusions: High-risk neonates with hypoplastic left heart syndrome or its variants can be successfully palliated using the hybrid strategy and bridged to a delayed Norwood or comprehensive stage II operation with satisfactory survival. This operative approach is a promising alternative pathway for neonates deemed to be high risk due to multiple preoperative risk factors.
AB - Objective: The study objective was to analyze outcomes of the hybrid strategy for ductal-dependent systemic circulation consisting of bilateral pulmonary artery banding with or without ductal stenting followed by delayed Norwood-type palliation or comprehensive stage II operation in high-risk neonates. Methods: A retrospective analysis was performed between December 2017 and March 2021. Thirty high-risk neonates underwent palliation with bilateral pulmonary artery banding: 11 with prostaglandin therapy and 19 with ductal stenting. Median (range) age and body weight of patients at hybrid stage I were 3 days (0-43) and 2.9 kg (1.1-4.2), respectively. Operative and interstage mortality, morbidity, and reintervention rates were assessed. Results: Overall survival was 70% (21/30) at a median follow-up time of 9 months (range, 0-37) from hybrid stage I. Operative survival for hybrid stage I was 90% (27/30), of which 2 patients received palliative care, and there was 1 interstage death (4%, 1/27). After hybrid stage I, 37% of patients had a reintervention, and 3% (n = 1) used extracorporeal membrane oxygenation before the next stage of repair. Five patients are awaiting second-stage operation, and 9 patients are awaiting Fontan completion. Conclusions: High-risk neonates with hypoplastic left heart syndrome or its variants can be successfully palliated using the hybrid strategy and bridged to a delayed Norwood or comprehensive stage II operation with satisfactory survival. This operative approach is a promising alternative pathway for neonates deemed to be high risk due to multiple preoperative risk factors.
UR - https://www.scopus.com/pages/publications/85123986971
UR - https://www.scopus.com/pages/publications/85123986971#tab=citedBy
U2 - 10.1016/j.jtcvs.2021.11.103
DO - 10.1016/j.jtcvs.2021.11.103
M3 - Article
C2 - 35577592
AN - SCOPUS:85123986971
SN - 0022-5223
VL - 164
SP - 1291-1303.e6
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 5
ER -